tm logo

Monitor this mark

View On USPTO

TREANDA (BENDAMUSTINE HCI) FOR INJECTION
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 14 Sep 2021

Last Applicant/ Owned by

CEPHALON LLC

145 BRANDYWINE PARKWAY

WEST CHESTER

PA

19380

Serial Number

86088292 filed on 10th Oct 2013

Registration Number

4696840 registered on 03rd Mar 2015

in the Principal Register

Correspondent Address

Laurence Rickles

Laurence Rickles TEVA PHARMACEUTICALS USA, INC.

Building A

Parsippany, NJ 07054

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

TREANDA (BENDAMUSTINE HCI) FOR INJECTION

Pamphlets and brochures containing information regarding the treatment of cancer

Classification Information

Class [016]
Paper Goods and Printed Material

Pamphlets and brochures containing information regarding the treatment of cancer

First Use Date in General

17th Nov 2014

First Use Date in Commerce

17th Nov 2014

Mark Details

Serial Number

No 86088292

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TEV0870TUS

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History

Show more

Status DateAction Taken
27th Jun 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
27th Jun 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27th Mar 2024TEAS SECTION 8 & 9 RECEIVED
03rd Mar 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07th Dec 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
14th Sep 2021AMENDMENT UNDER SECTION 7 - PROCESSED
14th Sep 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
14th Sep 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09th Sep 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
14th Jul 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED